03:51 AM EDT, 06/21/2024 (MT Newswires) -- Lantheus ( LNTH ) has agreed to make an initial strategic equity investment of 7.5 million Australian dollars ($5 million) in the company, Radiopharm said on Friday.

The US-based pharmaceutical company will also have the option to invest a further AU$7.5 million within six months on the same terms.

Radiopharm has agreed to transfer two of its early preclinical assets to Lantheus ( LNTH ) for AU$3 million.

The company will use the net proceeds of Lantheus' ( LNTH ) investment for drug manufacturing, clinical trials and general working capital.

Price: 82.00, Change: +0.52, Percent Change: +0.64